Delivering consistent and scalable mammalian-derived products, Scorpius uses its American facilities to advance your drug from R&D to the clinic and beyond.
Scorpius has ~5,400 sq. ft. of its contract biomanufacturing facility in San Antonio, Texas for mammalian cell culture and harvest and downstream processes operations.
The facility’s multi-modal design contains seven cGMP-compliant controlled cleanrooms that utilize single-use systems to allow for greater flexibility, enhanced sterility assurance, and faster processing times with increased productivity.
Fill out the form on the right to download the brochure >>>